Abstract:Highlights • LUZP1 expression was progressively increased in hearts after TAC surgery. • Cardiac-specific LUZP1 deficiency aggravated pressure overload-induced cardiac hypertrophy. • Cardiac-specific LUZP1 overexpression attenuated pressure overload-induced cardiac hypertrophy. • Stat3 pathway was a downstream target of LUZP1 in regulating pathological cardiac hypertrophy. • LUZP1 elevated SHP1 expression to inactivate Stat3 pathway. Introduction Cardiac hypertrophy is an important contributor of heart failure, and the mechanisms remain unclear. Leucine zipper protein 1 (LUZP1) is essential for the development and function of cardiovascular system; however, its role in cardiac hypertrophy is elusive. Objectives This study aims to investigate the molecular basis of LUZP1 in cardiac hypertrophy and to provide a rational therapeutic approach. Methods Cardiac-specific Luzp1 knockout (cKO) and transgenic mice were established, and transverse aortic constriction (TAC) was used to induce pressure overload-induced cardiac hypertrophy. The possible molecular basis of LUZP1 in regulating cardiac hypertrophy was determined by transcriptome analysis. Neonatal rat cardiomyocytes were cultured to elucidate the role and mechanism of LUZP1 in vitro. Results LUZP1 expression was progressively increased in hypertrophic hearts after TAC surgery. Gain- and loss-of-function methods revealed that cardiac-specific LUZP1 deficiency aggravated, while cardiac-specific LUZP1 overexpression attenuated pressure overload-elicited hypertrophic growth and cardiac dysfunction in vivo and in vitro. Mechanistically, the transcriptome data identified Stat3 pathway as a key downstream target of LUZP1 in regulating pathological cardiac hypertrophy. Cardiac-specific Stat3 deletion abolished the pro-hypertrophic role in LUZP1 cKO mice after TAC surgery. Further findings suggested that LUZP1 elevated the expression of Src homology region 2 domain-containing phosphatase 1 (SHP1) to inactivate Stat3 pathway, and SHP1 silence blocked the anti-hypertrophic effects of LUZP1 in vivo and in vitro. Conclusion We demonstrate that LUZP1 attenuates pressure overload-induced cardiac hypertrophy through inhibiting Stat3 signaling, and targeting LUZP1 may develop novel approaches to treat pathological cardiac hypertrophy. Graphical abstract LUZP1 expression was increased in pressure overload-induced cardiac hypertrophy in postnatal mice. By constructing cardiac-specific Luzp1 knockout and transgenic mice, we demonstrated that cardiac-specific LUZP1 deficiency aggravated, while cardiac-specific LUZP1 overexpression attenuated pressure overload-induced cardiac hypertrophy and dysfunction. Mechanistically, LUZP1 elevated SHP1 expression to inactivate Stat3 pathway, thereby preventing pathological cardiac hypertrophy. Accordingly, SHP1 silence blocked the anti-hypertrophic effects of LUZP1 in vivo and in vitro. Download : Download high-res image (150KB) Download : Download full-size image

LUZP1 regulates the maturation of contractile actomyosin bundles

ZO-1 interactions with F-actin and occludin direct epithelial polarization and single lumen specification in 3D culture

Myosin-18B Promotes Mechanosensitive CaMKK2-AMPK-VASP Regulation of Contractile Actin Stress Fibers

Neuronal Wiskott-Aldrich Syndrome Protein (N-WASP) is Critical for Formation of Α-Smooth Muscle Actin Filaments During Myofibroblast Differentiation.

Leucine zipper protein 1 attenuates pressure overload-induced cardiac hypertrophy through inhibiting Stat3 signaling

Initiation of Lumen Formation from Junctions via Differential Actomyosin Contractility Regulated by Dynamic Recruitment of Rasip1

Tension-dependent stretching and folding of ZO-1 controls the localization of its interactors

Piezo1 incorporates mechanical force signals into the genetic program that governs lymphatic valve development and maintenance

Piezo1-Regulated Mechanotransduction Controls Flow-Activated Lymphatic Expansion

LIMD1 Phase Separation Contributes to Cellular Mechanics and Durotaxis by Regulating Focal Adhesion Dynamics in Response to Force

LonP1 Links Mitochondria-ER Interaction to Regulate Heart Function.

LIMK2 is required for membrane cytoskeleton reorganization of contracting airway smooth muscle

The Zinc Finger Protein Zfpm1 Modulates Ventricular Trabeculation Through Neuregulin-ErbB Signalling.

Plexin-B2 orchestrates collective stem cell dynamics via actomyosin contractility, cytoskeletal tension and adhesion

Depletion of Zebrafish Essential and Regulatory Myosin Light Chains Reduces Cardiac Function Through Distinct Mechanisms

RSU-1 Maintains Integrity of Caenorhabditis elegans Vulval Muscles by Regulating α-actinin.

FHOD-1/profilin-mediated actin assembly protects sarcomeres against contraction-induced deformation in

Myosin 1D and the branched actin network control the condensation of p62 bodies

β-heavy-spectrin stabilizes the constricting contractile ring during cytokinesis

Spatiotemporal coordination of actin regulators generates invasive protrusions in cell–cell fusion

Oscillatory contractile forces refine endothelial cell-cell interactions for continuous lumen formation governed by Heg1/Ccm1